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Real‐time monitoring and control of protein A capture steps by process analytical
technologies (PATs) promises significant economic benefits due to the improved usage
of the column's binding capacity, by eliminating time‐consuming off‐line analytics and
costly resin lifetime studies, and enabling continuous production. The PAT method
proposed in this study relies on ultraviolet (UV) spectroscopy with a dynamic back-
ground subtraction based on the leveling out of the conductivity signal. This point in
time can be used to collect a reference spectrum for removing the majority of spectral
contributions by process‐related contaminants. The removal of the background spec-
trum facilitates chemometric model building and model accuracy. To demonstrate the
benefits of this method, five different feedstocks from our industry partner were used
to mix the load material for a case study. To our knowledge, such a large design space,
which covers possible variations in upstream condition besides the product con-
centration, has not been disclosed yet. By applying the conductivity‐based background
subtraction, the root mean square error of prediction (RMSEP) of the partial least
squares (PLS) model improved from 0.2080 to 0.0131 g −L 1. Finally, the potential of the
background subtraction method was further evaluated for single wavelength‐based
predictions to facilitate implementation in production processes. An RMSEP of 0.0890 g
−L 1 with univariate linear regression was achieved, showing that by subtraction of the
background better prediction accuracy is achieved then without subtraction and a PLS
model. In summary, the developed background subtraction method is versatile, enables
accurate prediction results, and is easily implemented into existing chromatography
setups with typically already integrated sensors.
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1 | INTRODUCTION
The profitability of biopharmaceutical companies is decreasing (Thakor
et al., 2017) due to decreasing research and development (R&D) pro-
ductivity and increased drug price competition from biosimilars (Kessel,
2011). Therefore, the sector is looking to reduce costs in R&D and pro-
duction by automation of the production processes (Grilo &
Mantalaris, 2019; Rantanen & Khinast, 2015). The implementation of PAT
is key for the digital transformation and automation of processes to gain a
competitive edge over business rivals. As automation in the downstream
process is economically most valuable for protein A capture steps due to
the high costs of protein A resin, this area has received a lot of attention
(Rüdt et al., 2017), especially in the past year (Feidl, Garbellini, Vogg, et al.,
et al., 2019; Thakur et al., 2019). Rüdt et al. (2017) published an approach
in 2017, where ultraviolet and visible (UV/Vis) spectra were used to
monitor the breakthrough of a protein A column and to control the load
phase, if a certain concentration in the breakthrough was reached. While
the approach itself is interesting, little explanation was given in the article
on the used PLS model and what spectral changes it leverages. Ad-
ditionally, a background subtraction at a constant UV signal was necessary
to improve the prediction for low concentrations as the change in host cell
protein (HCP) in different feeds influenced the model. This background
subtraction at constant absorption is difficult, as a displacement of HCP
species or highly concentrated feedstock can lead to insufficient fulfillment
of UV criteria and thereby to the failure of the method.
Feidl, Garbellini, Luna et al. (2019) and Feidl, Garbellini, Vogg, et al.
(2019) published an approach to monitor the breakthrough with Raman
spectroscopy. Due to the low scatter efficiency of proteins, measurement
times of 30 s per spectra were necessary (Feidl, Garbellini, Luna, et al.,
2019; Feidl, Garbellini, Vogg, et al., 2019) and with an average of two
spectra (Feidl, Garbellini, Vogg, et al., 2019), resulting in a measurement
time of 1min. Measurement times of 1min can be insufficient for process
control, especially when looking at protein A membranes with high flow
rates and short load times. Even though measurement times per spectra
were quite high compared to UV/Vis, additional extensive data analysis
was necessary to remove high noise and make accurate predictions
possible.
A limitation of current publications is furthermore the comparably
small change in harvested cell culture fluid (HCCF) composition due to the
usage of only one or two feedstocks in each study. Rüdt et al. (2017) used
HCCF and mixed it with mock from a different cultivation. Feidl et al. used
HCCF from a perfusion reactor with two different monoclonal antibody
(mAb) concentration. Thakur et al. prepared flow‐through and purified
mAb from one batch of HCCF for a near‐infrared (NIR)‐based control for
continuous chromatography. In all three studies, the calibration space was
thus spanned by only one or two HCCF batches. Since inter‐batch var-
iations can result in a significant impact on HCP composition and
DNA content (Goey, 2016), the obtained models may be limited in their
predictive power for an independent HCCF batch.
To tackle sensor complexity and model validity over upstream fluc-
tuations in this study, a product containing HCCF was mixed with three
different mock materials and purified bispecific mAb. This accounts for
various changes in the cell line, cell culture medium, host cell profile, and
also for changes in the bispecific product profile due to the changes in the
concentration of mispaired species relative to the product. Due to the
increased and random variability compared to previous studies, a pre-
diction of the mAb concentration in the breakthrough becomes more
challenging. To compensate the increased variability in the background, a
novel background subtraction method was developed in this study. Spe-
cifically, a background spectrum is subtracted when the conductivity
reaches a stable point. This allows to determine the breakthrough of the
flow‐through as the protein concentration contributes very little to the
overall conductivity of the HCCF.
Finally, the usage of single wavelength absorption in combination with
the conductivity‐based background subtraction for product concentration
prediction in the effluent is evaluated. The use of only one absorption
wavelength and conductivity allows for an easy implementation of load
control strategies in current manufacturing processes as those sensors are
typically implemented in chromatographic equipment.
2 | MATERIALS AND METHODS
2.1 | Biologic material and buffers
All biologic material was stored at ∘5 C before experimentation after
delivery from our industry partner. To obtain a variable mAb
concentration—in this study a bispecific mAb—a variable mispaired
species to product ratio, and a variable impurity profile in the load
material, the product containing HCCF (Feedtsock 1) with a product
concentration of −2 g L 1 was mixed with purified product (Feedstock 2)
and three different mock HCCFs solutions (Feedstock 3–5). One mock
solution was cultivated with a nonproducing cell line. The other two
mock solutions were prepared as flow‐through by preparative protein
A chromatography. These two mock solutions were derived from
HCCFs of two different cell lines, which produce two different mAbs,
respectively. Before this study, it was ensured that the protein A flow‐
through did not contain antibodies in detectable concentrations
(based on analytical protein A chromatography). For product spiking,
the used bispecific mAb (Feedstock 2) was purified to the second
polishing step by our industry partner and was concentrated up to 20
g −L 1 to reduce dilution effects of the impurities by addition of the
concentrated product.
In the product containing HCCF (Feedstock 1), different mis-
paired species were present, while the purified product (Feedstock 2)
only contained the desired mAb. By mixing the product containing
HCCF with the purified product, variation in the concentration of the
different mAb species was introduced into the design space as well.
The product containing HCCF, purified mAb, and the three mock
HCCFs were filtered with a cellulose acetate filter with a pore size
of μ0.22 m (Pall Corporation, Port Washington, NY, USA) before
mixing. In Table 1, the used volume of the different stock materials for
each run are shown. The composition of the mixtures between the
three mock materials was determined by Latin hypercube sampling to
provide a random multidimensional distribution.
For all preparative runs, the following buffers were applied:
Equilibration with 25 mM TRIS and 0.1 M sodium chloride at pH 7.4,
wash with 1 M TRIS and 0.5 M potassium chloride at pH 7.4, elution
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with 20mM citric acid at pH 3.6, sanitization with 50mM sodium
hydroxide and 1M sodium chloride, and storage with 10mM sodium
phosphate, 130mM sodium chloride, 20% ethanol.
For analytical protein A chromatography, column equilibration was
carried out using a buffer with 10 mM phosphate (from sodium phos-
phate and potassium phosphate) with 0.65M chloride ions (from sodium
chloride and potassium chloride) at pH 7.1. Elution was performed with
the same buffer, but titrated to pH 2.6 with hydrochloric acid. All buffer
components were purchased from VWR. The buffers were prepared with
Ultrapure Water (PURELAB Ultra, ELGA LabWater, Viola Water Tech-
nologies, Saint Maurice, France), filtrated with a cellulose acetate filter
with a pore size of μ0.22 m (Pall), and degassed by sonification.
2.2 | Chromatographic instrumentation
All preparative runs were realized with an Äkta Pure 25 purification
system controlled with Unicorn 6.4.1 (GE Healthcare). The system was
equipped with a sample pump S9, a fraction collector F9‐C, a column
valve kit (V9‐C, for up to 5 columns), a UV‐monitor U9‐M (2mm path-
length), a conductivity monitor C9, a pH valve kit (V9‐pH) and an I/O‐box
E9. Additionally, an UltiMate 3000 diode array detector (DAD) equipped
with a semipreparative flow cell (0.4mm optical pathlength) and operated
with Chromeleon 6.8 (Thermo Fisher Scientific) was connected to the
Äkta Pure. The DAD was positioned between the conductivity monitor
and the V9‐pH valve. Additionally, a second sensor and flow cell were
positioned before the DAD. The data was not used for this study.
Reference analysis of collected fractions was performed using a
Vanquish Flex Binary High‐Performance Liquid Chromatography (HPLC)
system (Thermo Fisher Scientific) by analytical protein A chromato-
graphy. The system consisted of a Binary Pump F, Split Sampler FT,
Column Compartment H and a Diode Array Detector HL. Chromeleon
Version 7.2 SR4 (Thermo Fisher Scientific) was used to control the HPLC.
2.3 | Chromatography runs
To generate variable mixtures between the product bispecific mAb,
mispaired species and, other impurities for the PLS model calibration
and validation, breakthrough experiments with variable mAb titers in
the feed were performed. The mAb titers in the different load materials
were 1, 1.5, 2, 2.5, and 3 g −L 1. For each experiment, a prepacked
×5 50 mm, MabSelect SuRe column (0.982ml; Repligen) was first
equilibrated for 5 column volumes (CV) and then loaded with 100mg of
mAb. At the beginning of the load phase, the DAD equipped with a
semipreparative flow cell (optical pathlength 0.4mm) was triggered to
record absorption spectra from 200 to 800 nm and the column flow‐
through was collected in μ200 L fractions.
2.4 | Analytical chromatography
The collected fractions of all runs were examined by analytical protein A
chromatography to obtain the mAb concentrations. For each sample, a
×2.1 30 mm POROS prepacked protein A column (Applied Biosystems)
was equilibrated with 2 CV of equilibration buffer, flowed by an injection
of μ20 L of sample. The column was then equilibrated with 0.8 CV of
equilibration buffer and eluted with 1.4 CV of elution buffer. The flow
rate was 2 mLmin−1 for all phases and experiments.
2.5 | Data analysis
The data analysis workflow is depicted in Figure 1. The recorded 3D field,
results from the analytical chromatography, and run data from the Äkta
system were read in and pre‐processed with MATLAB 2019R (The
MathWorks, Inc.). From the conductivity data, the stable point of the
conductivity was determined by smoothing the data with a moving mean
filter with a window size of 5 s. If the conductivity did not change in the
third decimal point for 10 s after the first CV, the conductivity was seen
as stable. This point was used to subtract the background spectrum from
the UV spectra, as depicted in Figure 2. The goal of this background
subtraction is to remove signal originating from contaminants from the
spectrum to improve product concentration predictions.
The background subtraction was performed by subtracting the
measured UV spectrum closest to the stable point of the conductivity.
The spectra were averaged according to the fraction size data from the
Äkta. For the correlation of the averaged absorption spectra with the
mAb concentrations, PLS models were calibrated using SIMCA 13.0.3
(Sartorius). SIMCA applies the Nonlinear Iterative Partial Least Squares
algorithm for PLS model building (Eriksson et al., 2006). Before the PLS
model calibration, all spectra and the mAb concentration were pre-
treated by mean‐centering using SIMCA. For the calibration of the PLS
model, Runs 1–4 were used as calibration data set. SIMCA applies a
TABLE 1 Sample composition for the
calibration runs 1–4 and the validation run 5
with volumes of the product containing HCCF
(Feedstock 1), purified mAb (Feedstock 2),
mock HCCF (Feedstock 3), and flow‐through 1
and 2 (Feedstock 4 and 5)







Run 1 Calibration 52.50 0.00 9.85 21.91 20.74
Run 2 Calibration 35.00 1.75 14.82 1.36 17.08
Run 3 Calibration 21.00 3.15 6.48 3.93 7.44
Run 4 Calibration 17.50 3.50 6.57 6.13 1.30
Run 5 Validation 26.25 2.63 2.01 12.65 8.96
Abbreviations: HCCF, harvested cell culture fluid; mAb, monoclonal antibody.
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F IGURE 1 Experimental procedure for the PLS model calibration with background correction: For each calibration run, 200 μl fractions were
collected and analyzed by analytical protein A chromatography to obtain the mAb breakthrough curves. During the breakthrough, 3D
chromatograms and the conductivity were recorded. When the initial breakthrough of impurities was completed, determined by the stability of
the conductivity signal, this background spectrum (highlighted red in 3D field) was subtracted from the 3D‐field. Then the averaged spectra
corresponding to the fraction size were calculated from the background‐corrected absorption 3D‐field. Averaged spectra and mAb
concentrations were correlated using PLS modeling. 3D, three‐dimensional; mAb, monoclonal antibody; PLS, partial‐least square [Color figure
can be viewed at wileyonlinelibrary.com]
F IGURE 2 The goal of the background subtraction is to determine the complete breakthrough of the HCCF background by conductivity and
to subtract the spectrum at complete background breakthrough. Through this most effects of the background are removed from the spectrum
and estimation of the mAb concentration can be improved. Additionally, background effects in the HCCF due to changing conditions in the
medium, HCP profile or DNA amount are excluded. HCCF, harvested cell culture fluid; HCP, host cell protein; mAb, monoclonal antibody [Color
figure can be viewed at wileyonlinelibrary.com]
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seven‐fold cross validation as internal validation. The number of latent
variable (LV) was determined by the autofit function of SIMCA. Run 5
was chosen as external validation.
The model complexity, in this case the number of LV, is important for
the robustness of the model (Eriksson et al., 2006). It is important to find
the right compromise between fit and predictive ability of the model.
While an increase in LVs increases the fit of the model, also noise in the
data can be fitted, which reduces the prediction ability of the model for
new data with unknown noise or other non‐idealities (Kessler, 2007).
3 | RESULTS AND DISCUSSION
In this study, the breakthrough of mAb during the protein A load phase
was monitored by UV spectroscopy in combination with a PLS model.
To calibrate the PLS model, four chromatographic runs
(Runs 1–4) at mAb concentrations of 1, 1.5, 2.5, and 3 g −L 1 in the feed
were performed and analyzed by off‐line analytics. The actual con-
centration in the load material were slightly higher due to inaccuracies
in the initial titer measurement of the HCCF and purified product. A
validation run (Run 5) was performed at a mAb concentration of 2 g
L−1 in the feed. Not only was the mAb concentration varied, but also
the composition of mock mixture to dilute the HCCF. This was done to
imitate possible variability in upstream processing, like changes in cell
culture medium, different amounts of DNA through different harvest
time points, and changes in the HCP profile. This variation generates a
large design space for model application.
Figure 3 compares the absorption at 280 nm A280 recorded by the
DAD to the conductivity recorded by the Äkta. The stability criterium of
the conductivity is reached between 6.6 to 10.6ml, depending on the
remaining buffer volume in the sample pump due to incomplete purging.
It can be seen, that while the conductivity is stable after this point, the
absorption at 280nm is still increasing due to the displacement of im-
purities. It has been shown, that DNA and certain HCP species interact
with the mAb bound to the Protein A resin (Aboulaich et al., 2014; Nogal
et al., 2012; Sisodiya et al., 2012; Van de Velde et al., 2020). This inter-
action can lead to a retention effect of the interacting impurities in
comparison to noninteracting impurities, which could lead to a delayed
breakthrough of the interacting impurities. The difference in interaction
strength between the impurities and the bound mAb could also lead to a
displacement of weakly interacting contaminants by stronger interacting
HCP species with progression of the load. The increase in absorption due
to the displacement, while no mAb breakthrough occurs, varies between
runs as the impurity profile varies. Therefore, the conductivity‐based
criterium is more robust for the background subtraction than a UV‐based
criterium.
3.1 | PLS model calibration and validation
The results of the model calibration without background sub-
traction are depicted in Figure 4. It compares the absorption at
280 nm A280 to the concentrations measured by off‐line analytics
and the prediction calculated by the calibrated PLS model. It can
be seen, that from the A280 alone, it is not possible to determine
the breakthrough of mAb, because no clear plateau is visible.
Likely, HCPs are displaced during loading which is overlaying
with the breakthrough of the mAb (Aboulaich et al., 2014,2006;
Shukla & Hinckley, 2008). The data show, that with decreasing
mAb concentration and increased background variation, the off-
set between the model prediction and actual concentration at low
concentrations is increasing. In Table 2, the coefficient of de-
termination R2, the cross‐validated coefficient of determination
Q2, the root mean square error of cross‐validation (RMSECV) and
number of LVs are compared for the model with background
subtraction and without. In general, the model with background
subtraction has a higher R2 and Q2 with 0.999 compared to 0.980,
respectively, for the model without background subtraction.
The results of the model calibration with background subtraction
are depicted in Figure 6. The PLS model fits the actual concentration
profile over the complete concentration range better than the model
without subtraction. The corrected absorption at 280 nm A280corr does
not plateau during the load, showing that conductivity‐based back-
ground subtraction is better suitable than a UV‐based criterium. To
further visualize the accuracy of both methods, an observed versus
predicted mAb concentration plot is discussed in the Appendix A.
Additionally, the PLS model with background subtraction has two
LVs compared to three LVs of the PLS model without background sub-
traction. In general, models with less LVs are preferred as the chances of
overfitting are smaller and therefore the robustness of the model can be
better.
Figure 5 compares the spectra of the uncorrected and corrected
data. Apparently, the background contributes most to the UV spec-
trum of the load material. Typically, the background contributes be-
tween 710 mAU to 768 mAU at 280 nm to the overall absorption,
while the mAb and the displaced proteins contribute between 0 mAU
to 162 mAU. This indicates, that other UV active components in the
load material besides the product are the main contributors to the
spectrum. The local spectral maxima shift for the not background‐
subtracted spectra from 271 nm towards 272 or 273 nm, depending
on the background spectrum. Probably different DNA concentrations
in the load material cause difference in the local maximum at same
concentration in different runs. DNA has a local absorption maximum
around 260 nm, which could cause the spectrum of the load material
to lay between 260 and 280 nm, depending on the DNA concentration.
The varied concentration of UV‐active components in the different
load materials is probably the reason for the shift and the different
total absorption values of the spectra without background subtraction
by mAb concentration in Figure 5. As the mAb concentration increases
the local maximum shifts in the direction of 280 nm, which is typically
considered as the local maximum of proteins (Langel et al., 2009).
The local maxima in the background‐corrected spectra (Figure 5b)
remain constant at 279 nm as soon as the mAb concentration starts to
increase. While the mAb concentration is still 0 g −L 1, the overall ab-
sorption still increases over time, may be due to a baseline drift by the
DAD. Additionally a small contribution of the background is visible.
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This may be caused by the displaced of impurities from the column due to
the binding of the mAb. Both phenomena could explain, why the ab-
sorption does not stay at 0 mAU for all wavelengths, while no mAb is
breaking through the column. To compare the background‐corrected
spectra with the absoprtion spectrum of the procduct, the absoprtion
spectrum during the elution of Run 1 is plotted in black in Figure 5b. The
absorption spectrum during the elution of Run 1 was normalized to





F IGURE 3 The absorption at 280nm A280 recorded by the DAD (displayed as blue line) is compared with the conductivity recorded by the Äkta
(teal line). The calculated stable point of the conductivity is indicated as black circle. All five runs exhibited variable mAb titers in the feed (a) 1 g −L 1,
(b) 1.5 g −L 1, (c) 2 g −L 1, (d) 2.5 g −L 1, and (e) 3 g −L 1. DAD, diode array detector; mAb, monoclonal antibody [Color figure can be viewed at
wileyonlinelibrary.com]
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readability. The elution spectrum has its local maximum at 279nm like
the background‐corrected spectra. The absorption in the elution spec-
trum around the local minimum at 252 nm is lower compared to the
background‐corrected spectra. This could be caused by impurities con-
tributing to the background‐corrected spectra. It seems more challenging
for the PLS model to extract the mAb concentration from the spectra
with the random variation in the background, because the PLS model
without background subtraction needs more LVs to fitted the data.
The spectra with background subtraction are ordered ac-
cording to mAb concentration and the local maximum stays at
279 nm, indicating that the spectrum originates from a protei-
nous source.
Additionally, from Figure 6 it seems, that the product con-
centration does not follow the absorption at 280 nm entirely, be-
cause the difference between the absorption and product
concentration grows bigger with increase in product concentration.
The higher the mAb concentration in the breakthrough the more
HCPs seem to be displaced from the column as the column saturates.
The results of the model validation without background subtraction
and with background subtraction are depicted in Figure 7. For the
prediction without background subtraction, an offset between the
actual mAb concentration at low protein concentration persists as in
the calibration data. Again, the model with background subtraction
fits the actual breakthrough at low concentration better. This is also
(a) (b)
(c) (d)
F IGURE 4 Results of the PLS model calibration without background subtraction. The absorption at 280 nmA280recorded by the DAD
(displayed as blue line) is compared with the results of the off‐line analytics for mAb quantification (orange bars). The PLS model prediction is
illustrated as orange lines. The four runs (Runs 1–4) exhibited variable mAb titers in the feed (a) 1 g −L 1, (b) 1.5 g −L 1, (c) 2.5 g −L 1, and
(d) 3 g −L 1. DAD, diode array detector; PLS, partial‐least square [Color figure can be viewed at wileyonlinelibrary.com]





in (gL 1− ) RMSEP (gL 1− )
Number
of LVs
No 0.980 0.980 0.1170 0.2080 3
Yes 0.999 0.999 0.0246 0.0131 2
Abbreviations: LV, latent variable; PLS, partial‐least square; RMSECV,
root mean square error of cross‐validation; RMSEP, root mean square
error of prediction.
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represented in the RMSEP of 0.0131 g L−1 of the model with back-
ground subtraction compared with the RMSEP of 0.2080 g L−1 of the
model without background subtraction (see Table 2).
Additionally, we provide the limit of detection (LOD) and the
limit of quantification (LOQ) of both models with and without
background subtraction in the Appendix C.
3.2 | Comparison to other publications
To set the results of this study into perspective to recent publications, the
results are compared to the obtained results by (Thakur et al., 2019) for
the usage of NIR spectroscopy to monitor the breakthrough and to the
results by (Feidl, Garbellini, Vogg, et al., 2019) for the usage of Raman
spectroscopy. As these studies were carried out on different data set and
different steps for model optimization were undertaken, a final conclu-
sion cannot be drawn by solely comparison of the results. However, a
comparison can give a general steer on which method might be the most
suitable for the monitoring of the Protein A load phase.
Thakur et al. (2019) published an RMSEP for the breakthrough ex-
periments in their publication of 0.1540 g −L 1 for NIR spectroscopy in
combination with PLS models. This error is almost 10‐fold higher than the
RMSEP of 0.0186 g −L 1 for the model with background subtraction from
this article. As it is sometimes misleading to compare RMSEPs due to
difference in involved sample concentration and sample distribution in
the design space, it would be better to as well compare the goodness of
fit R2 and the goodness of prediction during cross‐validation Q2 values.
However, the coefficient of determination R2 mentioned in the paper
must not be mistaken for the goodness of fit R2, as the coefficient of
determination describes only the goodness of fit of the regression line on
the observed versus predicted plot and not on the actual prediction.
Another point to consider is, that no orthogonal off‐line analytic was
performed by Thakur et al. It remains unclear, how the actual mAb
concentration was calculated, if it was not measured. Also, the chemo-
metric side of the data analysis is not explained. This makes it difficult to
evaluate, whether an effect caused by the actual difference in mAb
concentration was measured or an effect due to the mixture of the
feedstocks is correlated to the mAb concentration. Additionally, a more
challenging design space presented in this study, as five different feed-
stocks were used compared to one in the case study by Thakur et al.
Therefore, it is difficult to compare the NIR‐based model with
the UV‐based models. With the presented evidence, however, we
would conclude that UV‐based models seem to have a lower pre-
diction error compared to NIR‐based methods. This is also in good
agreement with literature, which generally concludes, that UV ab-
sorption spectroscopy has higher accuracy due to the low impact of
temperature and water background on the spectra (Kessler, 2012;
Rolinger et al., 2020; Swartz, 2010).
The same can be said about Raman spectroscopy, which is also
reported to have a lower accuracy and higher limit of detection in
comparison to UV absorption spectroscopy for proteins (Kessler,
2012; Rolinger et al., 2020; Swartz, 2010). An average RMSEP of
0.12 g −L 1 was published by (Feidl, Garbellini, Vogg, et al., 2019) for
the breakthrough monitoring with Raman spectroscopy and PLS
modeling in a concentration range, which is comparable to this study.
This is again an almost 10‐fold higher RMSEP as for the model with
background subtraction presented in this study. Also extensive che-
mometric model optimization was used to achieve this RMSEP,
(a) (b)
F IGURE 5 Comparison of the averaged spectra before (a) and after background subtraction (b). Every 20th spectrum is plotted. The spectra
are colored accordingly to the mAb concentration in the spectra from low concentration (blue) to high concentration (red). The local maxima of
the spectra are highlighted with black circles. It is shown, that without the background subtraction, the positions of the local maximum shift with
higher mAb concentration closer from 264 nm towards 270 nm. For the background‐subtracted spectra, the position of the local maxima stay
consistent at 279 nm after the initial breakthrough. Highlighted in black is a normalized absorption spectrum during the elution of Run 1. mAb,
monoclonal antibody [Color figure can be viewed at wileyonlinelibrary.com]
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(a) (b)
(c) (d)
F IGURE 6 Results of the PLS model calibration with background subtraction. The absorption at 280 nm A280 recorded by the DAD
(displayed as blue line) is compared with the results of the off‐line analytics for mAb quantification (orange bars). The PLS model prediction is
illustrated as orange lines. The four runs (Runs 1–4) exhibited variable mAb titers in the feed (a) 1 g −L 1, (b) 1.5 g −L 1, (c) 2.5 g −L 1, (d) 3 g −L 1. DAD,
diode array detector; PLS, partial‐least square [Color figure can be viewed at wileyonlinelibrary.com]
(a) (b)
F IGURE 7 Results of the PLS model validation (Run 5). The absorption at 280 nm A280 recorded by the DAD and displayed as blue line) is
compared with the results of the off‐line analytics for mAb quantification (orange bars). The PLS model prediction is illustrated as orange lines.
(a) Model prediction without background subtraction and (b) the model prediction with background subtraction at a feed concentration of
2 g −L 1. DAD, diode array detector; PLS, partial‐least square [Color figure can be viewed at wileyonlinelibrary.com]
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whereas in this study no optimization was undertaken, as it was
not deemed necessary. In the next study, Feidl, Garbellini,
Luna, et al. (2019) investigated the usage of a lumped kinetic model
and an extended Kalman filter to improve the PLS model prediction
for low mAb concentrations. In the lower concentration range be-
tween 0 and 0.42 g −L 1, an RMSEP of 0.055 g −L 1 was achieved. The
implementation of an extended Kalman filter improved the RMSEP to
0.026 −L 1. Even an RMSEP of 0.026 g −L 1 is still almost double as high
as the best RMSEP of this study. Although the use of an extended
Kalman leads to a prediction improvement at first, the underlying
model can change during the lifetime of protein A column due to
column fouling, which could make the predictions worse in the long
run. Additionally, the Raman measurements were quite slow with a
total measurement time of 1 min (Feidl, Garbellini, Vogg, et al., 2019)
in comparison to NIR or UV measurements, which can be carried out
in less than a second. An RMSEP of 0.12 g −L 1 (Feidl, Garbellini, Vogg,
et al., 2019) obtained with Raman spectroscopy and an RMSEP of
0.026 g −L 1 (Feidl, Garbellini, Luna, et al., 2019) of Raman spectro-
scopy with an extended Kalman filter and extensive chemometric
processing. The RMSEP in this study is still lower even though the
concentration range was 10 times larger. It seems, that in general the
prediction obtained by Raman spectroscopy is more corrupted by
measurement noise and the use of a signal filter is obligatory to
derive a more reliable prediction compared to the raw prediction.
3.3 | Application of single wavelength UV‐
measurements
The implementation of a DAD is not standard in most production
processes. Therefore, the use of the absorption only at 280 nm was
tested, with and without background subtraction. In Table 3 the R2,
the Q2, the RMSECV and RMSEP are compared for the model with
background subtraction and without. Without background sub-
traction, the model cannot fit the breakthrough of mAb. The R2 and
Q2 are with 0.172 too low for spectroscopic models (Eriksson
et al., 2006) and the RMSEP is with 0.7348 g −L 1 too high for an
effective control of a protein A load phase. With background
subtraction, an R2 and Q2 of 0.985 and an RMSEP of 0.0890 g −L 1 are
achieved. This shows, that the background subtraction eliminates
most effects not caused by the increase in mAb concentration. In
Appendix D, a further visualization of the prediction capability of
the single wavelength approach is given. The simple linear
regression on a single wavelength with background subtraction al-
lows the implementation in production processes with already
available process sensor, that is, conductivity and absorption at
280 nm. No advanced chemometric methods are necessary. Instead,
the approach works almost out‐of‐the‐box. As the accuracy of the
sensors are crucial for the application, low‐noise sensors are re-
quired in the process.
4 | CONCLUSION AND OUTLOOK
In this study, a multisensor approach for real‐time monitoring of the load
phase in a protein A capture step was presented and compared to other
published approaches. The proposed method relies on a dynamic UV
background subtraction based on the leveling out of the conductivity
signal. The background‐corrected spectra can be used for product
breakthrough predictions in combination with a PLS model or by single
wavelength regression. In this study, a large design space with possible
variations arising during fermentation was created by using five different
feedstocks to mix the load material for the protein A step. The mixtures
account for possible changes in contaminant profile and concentration,
like buffer components, DNA, HCP, and mispaired species of the bispe-
cific mAb. It was demonstrated that by subtracting the background
spectrum during the breakthrough, the prediction of the mAb con-
centration is facilitated and improved compared models using the raw
spectra. The proposed method offers a robust quantification of the
product breakthrough regardless of large variability in the cell culture
fluid.
We conclude that UV‐based methods, especially with background
subtraction, yield better prediction accuracies than NIR‐ or Raman‐based
methods judged by the RMSEPs published in other publications (Feidl,
Garbellini, Luna, et al., 2019; Feidl, Garbellini, Vogg, et al., 2019; Thakur
et al., 2019). The application of the background subtraction to product
concentration determination with only one absorption wavelength shows
great potential for the application to production processes as the re-
quired sensors are already implemented in most processes.
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TABLE 3 R2, Q2, RMSECV, and RMSEP for both PLS models with
only 279 nm as input
Background
subtraction R2 Q2 RMSECV (g L 1− ) RMSEP (g L 1− )
No 0.172 0.172 0.7574 0.7348
Yes 0.985 0.985 0.101 0.0890
Abbreviations: PLS, partial‐least square; RMSECV, root mean square
error of cross‐validation; RMSEP, root mean square error of prediction.
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APPENDIX A: LINEARITY OVER CONCENTRATION
RANGE FOR THE PLS MODELS
Figure A1 shows the predicted mAb concentration over the observed/
measured mAb concentration for the PLS models with and without
background subtraction. Predicted and observed mAb concentrations
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show a linear relationship for both models. Deviations from the linear
relationship could be possibly caused by the off‐line analytic due to carry‐
over between samples. However the not background‐corrected models
show different offsets depending on the individual run. The largest offset
can be observed for Run 1. These offset could originate from the dif-
ferences in load material. The PLS model with background subtraction
shows no significant offsets, which seems to be a result of the removal of
different spectral contributions from the different feedstock material.
APPENDIX B: BACKGROUND COMPOSITION
All feedstocks used in this study could be differentiated by the
color of the HCCF. Figure B1 shows the different background
spectra, which were subtracted. As contaminants, like DNA, HCP,
some buffer componants and scattering molecules contribute to
this background spectrum, the diversity in the feedstock can be
spectrally assessed. Interestingly, the background spectra cluster
into 2 groups. Even though Runs 1 and 2 have a very different
composition, the background spectra look similar to Run 2 pos-
sibly having a higher DNA concentration due to the increased
absorption at 260 nm, but not at 280 nm. Also Runs 3–5 show
similar background spectra with regard to the total amount of
absorption, but also differ in the composition possibly due to
different DNA, HCP, and amount of large molecules, which cause
light scattering.
APPENDIX C: LIMIT OF DETECTION
The LOD and LOQ interval for the data set was calculated based on
the MATLAB code provided by Allegrini and Olivieri (2014). The
results are displayed in Table C1. If the background subtraction is
done, both the LOD and LOQ intervals are lower in comparison to
without background subtraction. Additionally are the intervals itself
smaller with background subtraction. The reduced spectral con-
tribution of interfering components due to the background subtrac-
tion could explain these findings, allowing for better detection and
quantification.
(a) (b)
F IGURE A1 Predicted mAb concentration by the PLS model over the measured (observed) mAb concentration for (a) the not background‐
corrected PLS model and (b) the background‐corrected PLS model. mAb, monoclonal antibody; PLS, partial‐least square
F IGURE B1 Comparison of the background spectra for the
calibration runs (Runs 1–4) and the validation run (Run 5)
TABLE C1 LOD interval and LOQ interval for multivariate models
with and without background subtraction
Background subtraction LOD interval (gL 1− ) LOQ interval (gL 1− )
Yes 0.0130–0.0144 0.039–0.043
No 0.0752–0.0940 0.226–0.282
Abbreviations: LOD, limit of detection; LOQ, limit of quantification.
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APPENDIX D: SINGLE WAVELENGTH PREDICTION
Figure D1 shows the predicted mAb concentration over the observed/
measured mAb concentration for the linear regression models with
and without background subtraction at 279 nm. The regression with-
out background subtraction shows large offsets for the different runs,
which seem to be driven by the contribution of the background
spectra (see Figure B1). The regression model with background sub-
straction shows little offsets. Only Run 4 seems to have a larger offset
compared to the other runs, which could be explained by a comparable
little earlier subtraction of the background as with the other runs.
Interestingly, even though the offsets are minimized by the back-
ground subtraction, the predicted mAb concentration over the ob-
served/measured mAb concentration show different slopes for the
different runs. This could be caused by the different interacting spe-
cies present in the load material, which are displaced at a different rate
from the column between the different runs.
(b)(a)
F IGURE D1 Predicted mAb concentration by the PLS model over the measured (observed) mAb concentration for (a) the not background‐
corrected PLS model and (b) the background‐corrected linear regression model. mAb, monoclonal antibody; PLS, partial‐least square
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